Clene Inc. Common Stock CLNN
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $34.00 (+665.8% upside)
Key Stats
- Today's Range
- $4.40 – $4.70
- 50-Day Range
- $3.25 – $6.55
- 52-Week Range
- $3.25 – $13.50
- Volume
- 66K shs
- Average Volume
- 131K shs
- Market Cap
- $61.83 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -2.50
- Price / Sales
- —
Short Interest
- Short Interest
- 0.30%
- Days to Cover
- 999.99
About Clene Inc. Common Stock
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Related Stocks
Compare head-to-head: CLNN vs LLY·CLNN vs JNJ·CLNN vs ABBV·CLNN vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.